V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005785 | 320004137 | 1.9 | null | Curative (C) | 2017-12-29 | 2018-02-02 | IVA | N | null | 320008714 | CARBOPLATIN + RT |
| 320005786 | 320004137 | 1.75 | 51.5 | Neo-adjuvant (N) | 2015-12-24 | 2017-02-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320008714 | RMS 2005 TRIAL |
| 320005787 | 320004140 | null | 82.1 | Palliative (P) | null | 2016-09-23 | CARBOPLATIN + ETOPOSIDE | null | null | 320008755 | FLUOROURACIL + MITOMYCIN |
| 320005788 | 320004142 | 1.77 | 93 | Palliative (P) | 2018-05-10 | 2018-05-16 | LANREOTIDE | Y | N | 320008755 | ECX |
| 320005789 | 320004143 | 1.64 | 53.8 | Neo-adjuvant (N) | 2013-10-31 | 2013-11-07 | Docetaxel 75mg/m2 (21 day) | N | N | 320008849 | CYCLOPHOSPHAMIDE |
| 320005790 | 320004144 | 1.56 | null | Palliative (P) | null | 2015-07-05 | GEMCITABINE | null | null | 320008851 | CARBOPLATIN + DOXORUBICIN |
| 320005791 | 320004145 | 1.71 | 73.7 | Palliative (P) | 2017-06-11 | 2017-06-11 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | N | N | 320008864 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005792 | 320004146 | 1.81 | 54.6 | Palliative (P) | 2016-01-08 | 2016-09-12 | CARBOPLATIN + FLUOROURACIL | 02 | N | 320008875 | TRASTUZUMAB |
| 320005793 | 320004148 | 1.65 | 72 | Palliative (P) | 2017-08-03 | 2017-12-07 | Docetaxel 75mg/m2 (21 day) | N | N | 320008881 | VEMURAFENIB |
| 320005794 | 320004150 | 1.6 | 97 | null | 2017-02-20 | 2017-02-21 | ICON8B TRIAL | 2 | null | 320008881 | ICON8B TRIAL |
| 320005795 | 320004151 | 1.7 | 36 | Palliative (P) | 2018-02-05 | 2018-02-12 | VINORELBINE | 02 | N | 320009166 | EOX |
| 320005796 | 320004152 | 1.63 | 70.3 | Not known (9) | 2018-01-11 | 2018-02-07 | Docetaxel | null | null | 320009166 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005797 | 320004153 | null | 59.9 | Palliative (P) | 2016-12-21 | 2017-02-01 | Temozolomide 150mg/m2 | N | N | 320009201 | DOXORUBICIN |
| 320005798 | 320007401 | 1.87 | 97.7 | Palliative (P) | 2017-01-04 | 2017-01-04 | Trastuzumab Subcutaneous | N | N | 320009233 | CAP |
| 320005799 | 320007401 | 1.6 | 132 | Palliative (P) | 2017-04-09 | 2017-04-19 | Sunitinib | N | N | 320009233 | CISPLATIN + CYCLO + DOXORUBICIN |
| 320005800 | 320006732 | null | 94.7 | Palliative (P) | 2016-05-31 | 2017-04-10 | CAPECITABINE + OXALIPLATIN | 02 | N | 320009246 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005801 | 320006732 | 1.48 | null | null | null | 2018-03-18 | ICON8 TRIAL | null | null | 320009246 | CYCLOPHOSPHAMIDE |
| 320005802 | 320006732 | 1.71 | 97 | Palliative (P) | 2018-08-12 | 2018-08-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 320009246 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005803 | 320004155 | 1.51 | 61.8 | Curative (C) | 2018-10-03 | 2018-10-04 | IPM | 02 | N | 320009451 | CARBO + FLUOROURACIL |
| 320005804 | 320005905 | 1.64 | 85 | Palliative (P) | 2016-04-28 | 2016-05-03 | CARBOPLATIN + RT | 2 | N | 320009502 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 320005805 | 320004159 | 1.42 | 66.9 | Palliative (P) | 2018-05-24 | 2018-05-24 | Ipilimumab | N | N | 320009502 | IVA |
| 320005806 | 320004159 | 1.67 | 71.8 | Neo-adjuvant (N) | 2017-12-20 | 2017-12-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320009502 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005807 | 320004160 | 0 | 82.7 | Curative (C) | 2014-08-13 | 2014-08-20 | PEMBROLIZUMAB | N | Y | 320009627 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005808 | 320004161 | null | null | Palliative (P) | null | 2017-01-23 | Cetuximab +Cisplatin + FU (Cycle 1) | N | null | 320009627 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005809 | 320006736 | null | null | Palliative (P) | 2017-03-13 | 2017-04-02 | CETUXIMAB + CISPLATIN + FU | N | null | 320009693 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320005810 | 320006736 | 1.42 | 80 | null | 2016-12-02 | 2016-12-03 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | 320009693 | EURO-EWING |
| 320005811 | 320004162 | null | 56.1 | Palliative (P) | 2016-10-28 | 2016-11-23 | CARBOPLATIN + RT | N | N | 320009740 | DOCETAXEL |
| 320005812 | 320005908 | null | null | Adjuvant (A) | 2015-12-16 | 2015-12-31 | Docetaxel 75mg/m2 (21 day) | N | N | 320009740 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 320005813 | 320007132 | 1.72 | 67 | Adjuvant (A) | 2018-02-26 | 2018-03-31 | Irinotecan + Modified De Gramont | N | N | 320009798 | IRINOTECAN + TEMOZOLOMIDE |
| 320005814 | 320004163 | 1.6 | 62.4 | Palliative (P) | null | 2014-12-03 | PEMBROLIZUMAB | N | N | 320009996 | CARBO + FLUOROURACIL |
| 320005815 | 320004163 | 1.7 | 95 | Palliative (P) | 2015-02-28 | 2015-03-07 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 320009996 | CISPLATIN + VINORELBINE |
| 320005816 | 320004164 | null | 85 | Palliative (P) | 2018-10-29 | 2018-11-17 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 320010172 | CARBOPLATIN + CETUXIMAB + FU |
| 320005817 | 320004164 | null | 101 | Palliative (P) | null | 2018-01-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320010172 | CARBO + FLUOROURACIL |
| 320005818 | 320004164 | 1.72 | 77.1 | null | 2015-08-05 | 2015-08-05 | DOXORUBICIN | 02 | N | 320010172 | PEMBROLIZUMAB |
| 320005819 | 320004165 | 1.83 | 63 | Palliative (P) | 2015-01-31 | 2015-02-04 | PEMBROLIZUMAB | N | N | 320010593 | CARBOPLATIN + ETOPOSIDE |
| 320005820 | 320004165 | 1.76 | 63.7 | Palliative (P) | 2016-07-10 | 2016-07-11 | Carboplatin + Etoposide IV 3 day | 02 | Y | 320010593 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005821 | 320004166 | null | null | Palliative (P) | 2016-03-27 | 2016-04-21 | Sunitinib | 2 | N | 320011028 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005822 | 320004169 | 0 | 53 | Adjuvant (A) | 2014-03-06 | 2014-04-07 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320011028 | CETUXIMAB + CISPLATIN + FU |
| 320005823 | 320004170 | 1.62 | 87 | Palliative (P) | 2017-07-12 | 2017-07-12 | Temozolomide 200mg/m2 | 02 | N | 320011408 | CARBOPLATIN + ETOPOSIDE |
| 320005824 | 320005914 | 1.64 | null | Palliative (P) | null | 2018-06-02 | Capecitabine (14 days)+Carboplatin | null | null | 320011625 | ECX |
| 320005825 | 320004171 | 1.64 | 105 | Palliative (P) | 2015-02-25 | 2015-03-15 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 320011851 | VEMURAFENIB |
| 320005826 | 320004171 | 1.73 | 65.7 | Palliative (P) | 2016-10-07 | 2016-10-07 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320011851 | PEMBROLIZUMAB |
| 320005827 | 320004172 | 1.81 | 56.5 | Palliative (P) | null | 2017-10-24 | CARBOPLATIN + ETOPOSIDE | N | N | 320011994 | CYCLOPHOSPHAMIDE |
| 320005828 | 320004173 | null | 84.8 | Palliative (P) | null | 2016-02-09 | CETUXIMAB + RT | Y | N | 320012116 | DOCETAXEL |
| 320005829 | 320004174 | null | null | Curative (C) | 2016-07-25 | 2016-07-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320012126 | CETUXIMAB + RT |
| 320005830 | 320005917 | 1.91 | 109.6 | Curative (C) | 2014-04-29 | 2016-12-15 | Irinotecan + Modified De Gramont | N | Y | 320012129 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320005831 | 320004177 | 1.64 | 78 | Palliative (P) | 2017-07-31 | 2017-08-04 | PEMBROLIZUMAB | 02 | N | 320012147 | ICON8B TRIAL |
| 320005832 | 320004177 | null | 69 | Palliative (P) | 2017-03-05 | 2017-07-19 | Olaparib | N | N | 320012147 | DOCETAXEL |
| 320005833 | 320004178 | null | null | Palliative (P) | 2018-09-05 | 2018-10-17 | Bevacizumab+Carbo+Pacliaxel | N | N | 320012188 | CAV |
| 320005834 | 320004181 | null | 40.9 | Palliative (P) | 2018-01-13 | 2018-01-20 | Carbo F | N | null | 320012197 | EOX |